News

Kurin Commends the CDC for Their Recent Publication on Blood Culture Contamination

March 14, 2023

ENA Welcomes Kurin to 2023 Corporate Engagement Council

March 8, 2023

Kurin Announces Kurin Jet, A Quantum Leap Forward in Devices Designed to Address Blood Culture Contamination

February 15, 2023

Kurin, Inc. Reports Record Revenue for 2022

January 26, 2023

Kurin, Inc. Announces Successful FDA Audit

September 28, 2022

Kurin, Inc. Provides Update on Litigation Activity

September 15, 2022

Kurin, Inc. Announces Full Scale Manufacturing of Push-button Needle

September 7, 2022

Kurin, Inc. Statement Regarding Patent Litigation

August 3, 2022

U.S. District Court Enters Judgment of No Infringement of Patent Asserted Against Kurin Inc. by Magnolia Medical Technologies, Inc.

June 16, 2022

Kurin, Inc. Announces Launch of Its Proprietary Push-button Needle System

February 23, 2022

Kurin, Inc. Announces Agreement with AllSpire Health GPO to Impact Contaminated Blood Cultures

January 18, 2022

Kurin, Inc. Reports Record Sales for Q4 and Total 2021 Revenues

January 11, 2022

Kurin, Inc. Reports Record Q3 Sales

October 18, 2021

Kurin, Inc. announces UK clinical study results showing significant decrease in blood culture contaminations with the Kurin Lock™

October 5, 2021

Kurin, Inc. Reports Record Sales Month

August 10, 2021

Kurin, Inc. announces results on Kurin® efficacy from Oishei Children’s Hospital with zero blood culture contaminations

July 21, 2021

Kurin, Inc. Announces Removal of Magnolia Patent Infringement Lawsuit Trial Date

March 23, 2021

Kurin, Inc. announces peer-reviewed publication on Kurin® efficacy from Central Texas Veterans Health Care System

January 19, 2021

Kurin, Inc. honored by MD Tech Review in annual listing of top Infection Control solutions

December 24, 2020

Kurin, Inc. Named to Inc.’s Inaugural Best in Business List in the Prosperous and Thriving Category

December 8, 2020
1 2 3

ML-021 Rev A